GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 69 filers reported holding GENERATION BIO CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $131,752 | +120.0% | 30,640 | +101.0% | 0.00% | – |
| Q4 2022 | $59,893 | +46.1% | 15,240 | +95.6% | 0.00% | – |
| Q3 2022 | $41,000 | -19.6% | 7,790 | 0.0% | 0.00% | – |
| Q2 2022 | $51,000 | -10.5% | 7,790 | 0.0% | 0.00% | – |
| Q1 2022 | $57,000 | +3.6% | 7,790 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -99.7% | 7,790 | -98.8% | 0.00% | -100.0% |
| Q3 2021 | $15,738,000 | -19.6% | 627,763 | -13.7% | 0.03% | -15.4% |
| Q2 2021 | $19,578,000 | -4.0% | 727,796 | +1.6% | 0.04% | -11.4% |
| Q1 2021 | $20,394,000 | +145.7% | 716,576 | +144.7% | 0.04% | +131.6% |
| Q4 2020 | $8,301,000 | +22.6% | 292,817 | +33.7% | 0.02% | +11.8% |
| Q3 2020 | $6,769,000 | +146.1% | 218,969 | +67.2% | 0.02% | +142.9% |
| Q2 2020 | $2,750,000 | – | 131,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |